Jim Simons
OTLK icon

Jim Simons’s Outlook Therapeutics OTLK Stock Holding History

Jim Simons’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.5K Buy
+255,157
New +$110K ﹤0.01% 3107
2025
Q3 		– Sell
-106,068
Closed -$170K – 3793
2025
Q2 		$170K Buy
+106,068
New +$169K ﹤0.01% 3200
2025
Q1 		– Sell
-130,374
Closed -$246K – 3738
2024
Q4 		$246K Buy
+130,374
New +$536K ﹤0.01% 3103
2024
Q2 		– Sell
-17,600
Closed -$210K – 3840
2024
Q1 		$210K Buy
17,600
+12,329
+234% +$99.7K ﹤0.01% 3213
2023
Q4 		$42K Buy
+5,271
New +$44.6K ﹤0.01% 3482
2022
Q4 		– Sell
-2,515
Closed -$61K – 4316
2022
Q3 		$61K Sell
2,515
-8,055
-76% -$187K ﹤0.01% 3707
2022
Q2 		$216K Sell
10,570
-25,890
-71% -$744K ﹤0.01% 3617
2022
Q1 		$1.3M Sell
36,460
-21,755
-37% -$679K ﹤0.01% 2546
2021
Q4 		$1.58M Buy
58,215
+45,476
+357% +$1.62M ﹤0.01% 2337
2021
Q3 		$553K Buy
+12,739
New +$615K ﹤0.01% 2852
2021
Q2 		– Sell
-41,628
Closed -$1.87M – 3691
2021
Q1 		$1.87M Buy
41,628
+38,893
+1,422% +$1.49M ﹤0.01% 2275
2020
Q4 		$71K Sell
2,735
-2,605
-49% -$54.4K ﹤0.01% 3297
2020
Q3 		$77K Buy
+5,340
New +$119K ﹤0.01% 3246
2020
Q1 		– Sell
-1,970
Closed -$23K – 3690
2019
Q4 		$23K Buy
+1,970
New +$45.9K ﹤0.01% 3443
2019
Q2 		– Sell
-558
Closed -$83K – 3709
2019
Q1 		$83K Buy
+558
New +$78.8K ﹤0.01% 3319

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $995M AUM 22.79% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jim Simons's OTLK Position: Q1 2026 in Review

Jim Simons opened a new position in Outlook Therapeutics (OTLK) in Q1 2026: 255,157 shares worth $52.5K. The stake represents ﹤0.01% of the portfolio and ranks #3107 among its holdings. This is a return to the name: Jim Simons previously reported a position in OTLK as recently as Q2 2025.

Jim Simons first reported a position in OTLK in Q1 2019 and has held it in 15 quarters since. The position peaked at $1.87M in Q1 2021. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Jim Simons held 255,157 shares of Outlook Therapeutics worth $52.5K as of Q1 2026.
  • Outlook Therapeutics was a new Jim Simons position in Q1 2026.
  • Outlook Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3107 holding.
  • Jim Simons first reported a position in Outlook Therapeutics in Q1 2019 and has held it in 15 quarters since.
  • Jim Simons's Outlook Therapeutics position peaked at $1.87M in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.